BioCryst Pharmaceuticals Inc. (BCRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioCryst Pharmaceuticals ...

    NASDAQ: BCRX · Real-Time Price · USD
    8.27
    0.00 (0.00%)
    At close: Sep 05, 2025, 3:59 PM
    8.30
    0.36%
    After-hours: Sep 05, 2025, 05:51 PM EDT

    BioCryst Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 450.71M 331.41M 270.83M 157.17M
    Cost of Revenue
    		 12.27M 4.66M 6.59M 7.26M
    Gross Profit
    		 438.44M 325.1M 262.8M 149.13M
    Operating Income
    		 -2.54M -103.71M -148.44M -177.72M
    Interest Income
    		 14.75M 15.78M 5.13M 62K
    Pretax Income
    		 -86.95M -226.23M -244.38M -181.81M
    Net Income
    		 -88.88M -226.54M -247.12M -184.06M
    Selling & General & Admin
    		 266.13M 213.89M 159.37M 118.82M
    Research & Development
    		 174.64M 216.57M 253.3M 208.81M
    Other Expenses
    		 216K n/a n/a n/a
    Operating Expenses
    		 440.99M 430.46M 412.67M 118.82M
    Interest Expense
    		 98.52M 108.24M 99.09M 59.29M
    Selling & Marketing Expenses
    		 n/a 14.4M 14.89M 5.71M
    Cost & Expenses
    		 453.25M 435.12M 419.26M 334.89M
    Income Tax Expense
    		 1.93M 310K 2.73M 2.25M
    Shares Outstanding (Basic)
    		 206.7M 192.2M 185.91M 179.12M
    Shares Outstanding (Diluted)
    		 206.7M 192.2M 185.91M 179.12M
    EPS (Basic)
    		 -0.43 -1.18 -1.33 -1.03
    EPS (Diluted)
    		 -0.43 -1.18 -1.33 -1.03
    EBITDA
    		 12.81M -116.33M -143.85M -121.74M
    EBIT
    		 11.56M -117.99M -145.29M -122.52M
    Depreciation & Amortization
    		 1.25M 1.66M 1.44M 777K

    Add to Watchlist